SCHEMBL17636723

SCHEMBL17636723

CCOC(=O)Nc1ccc(Oc2ccc(OC)cc2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.77
NPC1 O15118 3/20 0.77
RAB9A P51151 3/20 0.77
CRHBP P24387 1/20 0.77
CRHR2 Q13324 1/20 0.77
MTNR1B P49286 2/20 0.62
TSHR P16473 1/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
MTNR1A P48039 1/20 0.56
MMP2 P08253 1/20 0.56
MMP9 P14780 1/20 0.56
MMP8 P22894 1/20 0.56
MMP14 P50281 1/20 0.56
KCNQ2 O43526 1/20 0.56
KDR P35968 1/20 0.56
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
LMNA P02545 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7556396 0.95 NPC1 (0.69) HPGDNPC1RAB9ACRHBPCRHR2
SCHEMBL9188320 0.93 HPGD (0.87) HPGDNPC1RAB9ACRHBPCRHR2
SCHEMBL8737482 0.89 NPC1 (0.79) HPGDNPC1RAB9ACRHBPCRHR2
SCHEMBL9091689 0.87 RAB9A (1.00) HPGDNPC1RAB9ACRHBPCRHR2
SCHEMBL11833154 0.84 HPGD (0.73) HPGDNPC1RAB9ACRHBPCRHR2
SCHEMBL7565510 0.84 RAB9A (0.71) HPGDNPC1RAB9ACRHBPCRHR2
SCHEMBL11790359 0.83 RAB9A (0.65) HPGDNPC1RAB9ACRHBPCRHR2
SCHEMBL21059104 0.82 SMN1; SMN2 (0.65) HPGDNPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL9515073 0.81 LMNA (0.69) HPGDNPC1RAB9ACRHBPCRHR2
SCHEMBL11394952 0.81 NPC1 (0.66) HPGDNPC1RAB9AMTNR1BSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9517651-B2 Developer for thermal recording media and thermal composition media using the same PERFORMANCE CHEMICALS, INC. (US) 2016-12-13 US disclosed
US-9517651-B2 Developer for thermal recording media and thermal composition media using the same PERFORMANCE CHEMICALS, INC. (US) 2016-12-13 US disclosed
US-20160089919-A1 NOVEL DEVELOPER FOR THERMAL RECORDING MEDIA AND THERMAL COMPOSITION MEDIA USING THE SAME MARUBENI AMERICA CORPORATION 2016-03-31 US disclosed
US-20160089919-A1 NOVEL DEVELOPER FOR THERMAL RECORDING MEDIA AND THERMAL COMPOSITION MEDIA USING THE SAME MARUBENI AMERICA CORPORATION 2016-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160089919-A1 NOVEL DEVELOPER FOR THERMAL RECORDING MEDIA AND THERMAL COMPOSITION MEDIA USING THE SAME HPD, PNMT, HTR3C HPGD 487/4885NPC1 4178/4885RAB9A 3234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.